Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. Beam Therapeutics
BEAM

Buy Beam Therapeutics (BEAM) Stock

BEAM
See BEAM stock price and Buy/Sell Beam Therapeutics with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
BEAM

Beam Therapeutics (BEAM)

About Beam Therapeutics (BEAM)

Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is...Read more
Market Cap
$3.64B
1 Year High
$100.06
Volume
531.51k
1 Year Low
$27.77
Price to Earnings Ratio
Open
$50.68
Dividend Rate
High
$51.28
Dividend Yield
Low
$48.54

Community

People who own or watch BEAM stock

Beam Therapeutics Price Targets

What analysts think BEAM stock price will be.
$50.95
$90.58
77.8% Upside
$26$106

Beam Therapeutics Stock Rating

What analysts recommend for BEAM stock, on a scale from 1(buy) to 5(sell).
Buy1.8 / 5
BuyHoldSell

Beam Therapeutics Stock Earnings

The value each BEAM share was expected to gain vs. the value that each BEAM share actually gained.
Expected
Actual

Beam Therapeutics Stock News

Frequently Asked Questions (FAQ)

As of Oct 04, 2022, the market cap for BEAM stock is $3.64B

The 52-week high for BEAM stock is $100.06. The current BEAM stock price $50.95 is 49.08% below its 52-week high

The 52-week low for BEAM stock is $27.77. The current BEAM stock price $50.95 has increased 45.50% from its 52-week low

No, the BEAM stock does not pay dividends to its shareholders

The target price for BEAM stock is $90.58 based on the average of what a group of analyst think BEAM stock could be worth at a future date. This is not a prediction by Public.com

Buy Beam Therapeutics (BEAM) Stock

BEAM
See BEAM stock price and Buy/Sell Beam Therapeutics with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch BEAM stock
  • GravityWagon avatar
  • Whitefriction avatar
  • emalms avatar
  • dnemet avatar
  • Fmfoto avatar
Products
Contact Us
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Brokerage services for US-listed, registered securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Our clearing firm, Apex Clearing Corporation, has purchased an additional insurance policy. The coverage limits provide protection for securities and cash up to an aggregate of $150 million, subject to maximum limits of $37.5 million for any one customer’s securities and $900,000 for any one customer’s cash. Similar to SIPC protection, this additional insurance does not protect against a loss in the market value of securities.

Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are over-the-counter equity securities that have been issued pursuant to Regulation A of the Securities Act of 1933 (as amended) (“Regulation A”). Dalmore and Open to the Public Investing are not affiliated entities. This content is not investment advice. These investments are speculative, involve substantial risks (including illiquidity and loss of principal), and are not FDIC or SIPC insured. The issuers of these securities may be an affiliate of Public, and Public (or an affiliate) may earn fees when you purchase or sell Alternative Assets. For more information on risks and conflicts of interest, see these disclosures. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification by the SEC or as stated in the offering materials relating to an investment opportunity, as applicable. An indication of interest to purchase securities involves no obligation or commitment of any kind.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures, Apex Crypto.

Dalmore and Apex Crypto, LLC are not affiliated with any of the Public Holdings subsidiaries.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S.-listed, registered securities electronically. Keep in mind that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more. All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.